Nov 9
Current report
8-K
Financial results
BFRI · Biofrontera Inc. · Documents
$0.83
+0.02 (+2.50%)
At close · Nov 6
Return incl. dividend (before tax)
Play latest call
Q1 2026 earnings call transcript
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management believes that these conditions raise substantial doubt about the Company's ability to continue as a going concern for at least twelve months from the issuance date of this Quarterly Report on Form 10-Q.”View the 10-Q filed Aug 13, 2026
Market Cap
$12.30M
Shares
14.85M
Volume · Nov 6
209.3K
Avg daily vol (3M)
490.11K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2023
Nov 9
Quarterly report
10-Q
FY2023 Q3, ended Sep 30
Quarterly report for FY2023 Q3
Revenue $8.9M
▲ 105.8%
Net loss $6.34M
Diluted EPS -$4.64
Nov 2
Current report
8-K
Events of Oct 30
Entered into a material agreement, Change to shareholders' rights, Regulation FD disclosure
Oct 27
Registration statement
S-1/A
Registration statement
Oct 16
Registration statement
S-1/A
Registration statement
Oct 13
Current report
8-K
Events of Oct 12
Entered into a material agreement
Oct 10
Current report
8-K
Regulation FD disclosure
Oct 5
Registration statement
S-1
Registration statement
Oct 4
Current report
8-K
Financial results
Oct 3
Current report
8-K
Events of Dec 31
Other events
Aug 11
Earnings call
Q2 2023 earnings call
Aug 11
Current report
8-K
Financial results
Aug 11
Quarterly report
10-Q
FY2023 Q2, ended Jun 30
Quarterly report for FY2023 Q2
Revenue $5.85M
▲ 31.2%
Net loss $9.84M
Diluted EPS -$7.23
Jul 13
Current report
8-K
Financial results
Jul 12
Current report
8-K
Events of Jul 7
Director or officer change, or executive pay, Regulation FD disclosure
Jul 3
Current report
8-K
Events of Jun 28
Change to shareholders' rights, Charter or bylaw amendment, or fiscal year change, Regulation FD disclosure
Jun 20
Current report
8-K
Events of Jun 16
Change of auditor
Jun 2
Current report
8-K
Events of May 30
Change of auditor
Jun 1
Current report
8-K
Regulation FD disclosure
May 30
Current report
8-K
Regulation FD disclosure
May 26
Current report
8-K
Events of May 22
Delisting notice or listing transfer, Director or officer change, or executive pay, Shareholder vote results
May 12
Earnings call
Q1 2023 earnings call
May 12
Current report
8-K
Events of May 8
Financial results, Director or officer change, or executive pay, Regulation FD disclosure
May 12
Quarterly report
10-Q
FY2023 Q1, ended Mar 31
Quarterly report for FY2023 Q1
Revenue $8.73M
▼ 10.4%
Net loss $7.48M
Diluted EPS -$0.28
Apr 28
Current report
8-K
Events of Apr 26
Entered into a material agreement, Change to shareholders' rights
Apr 21
Proxy statement
DEF 14A
Proxy statement
Apr 17
Current report
8-K
Events of Apr 11
Entered into a material agreement
Apr 11
Proxy statement
PRE 14A
Proxy statement
Mar 13
Annual report
10-K
FY2022, ended Dec 31
Annual report for FY2022
Revenue $28.67M
▲ 19.0%
Net loss $640K
Mar 8
Earnings call
Q4 2022 earnings call
Mar 8
Current report
8-K
Financial results
Mar 2
Current report
8-K
Events of Feb 24
Delisting notice or listing transfer
Jan 9
Current report
8-K
Financial results
2022
Dec 16
Current report
8-K
Events of Dec 12
Director or officer change, or executive pay, Shareholder vote results
Dec 8
Proxy statement
DEFA14A
Proxy statement
Nov 29
Proxy statement
DEFA14A
Proxy statement
Nov 21
Proxy statement
DEFA14A
Proxy statement
Nov 14
Earnings call
Q3 2022 earnings call
Nov 14
Current report
8-K
Financial results
Nov 14
Quarterly report
10-Q
FY2022 Q3, ended Sep 30
Quarterly report for FY2022 Q3
Revenue $4.32M
▼ 0.3%
Net loss $2.57M
Diluted EPS -$0.11
Nov 14
Proxy statement
DEFR14A
Proxy statement
Nov 9
Current report
8-K
Events of Nov 1
Regulation FD disclosure, Other events
Nov 8
Proxy statement
DEF 14A
Proxy statement
Nov 3
Registration statement
S-1
Registration statement
Oct 31
Current report
8-K
Events of Oct 25
Entered into a material agreement, Unregistered sale of equity, Regulation FD disclosure
Oct 24
Current report
8-K
Director or officer change, or executive pay, Regulation FD disclosure
Oct 14
Current report
8-K
Events of Oct 13
Entered into a material agreement, Change to shareholders' rights, Charter or bylaw amendment, or fiscal year change, Other events
Oct 5
Current report
8-K
Financial results
Aug 12
Earnings call
Q2 2022 earnings call
Aug 12
Current report
8-K
Financial results
Showing 101–150 of 188 documents